Charles River Laboratories International, Inc. announced the launch of Accugenix Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix NGS). Accugenix NGS simultaneously...
Horizon Therapeutics plc announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...
Jabil Inc. introduced PLA 3110P, a novel powder based on a renewably sourced biomaterial that offers a bio-based alternative to petrochemical-based powders, such as...
